VICENTE
ESTRADA PÉREZ
Profesor asociado de Ciencias de la Salud
Hospital Universitario La Paz
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Paz (45)
2024
-
Monkeypox virus genomic accordion strategies
Nature Communications, Vol. 15, Núm. 1
2023
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701
-
Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e116-e125
-
Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)
Open Forum Infectious Diseases
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278
-
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 9, pp. 2520-2528
2021
-
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633
-
Blood Bacterial Profiles Associated With Human Immunodeficiency Virus Infection and Immune Recovery
The Journal of infectious diseases, Vol. 223, Núm. 3, pp. 471-481
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19
Journal of hospital medicine, Vol. 16, Núm. 6, pp. 349-352
-
Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis
BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292
-
Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
BMC Infectious Diseases, Vol. 21, Núm. 1
-
Redefining therapeutic success in HIV patients: An expert view
Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2501-2518
-
Underlying heart diseases and acute covid-19 outcomes
Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214
2020
-
Increased Frequencies of Myeloid-Derived Suppressor Cells Precede Immunodiscordance in HIV-Infected Subjects
Frontiers in Immunology, Vol. 11
-
Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis
Frontiers in Endocrinology, Vol. 11